Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Crinetics Pharmaceuticals Inc | CRNX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 44.01 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 44.01 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 15.76 - 49.5799 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 44.01 | USD |
Crinetics Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.06B | 69.60M | - | 4.01M | -214.53M | -3.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Crinetics Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRNX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 46.54 | 48.73 | 43.25 | 44.92 | 656,512 | -2.53 | -5.44% |
| 1 Month | 45.86 | 49.5799 | 42.33 | 45.92 | 872,783 | -1.85 | -4.03% |
| 3 Months | 37.34 | 49.5799 | 35.70 | 42.24 | 818,964 | 6.67 | 17.86% |
| 6 Months | 28.91 | 49.5799 | 25.75 | 37.14 | 831,809 | 15.10 | 52.23% |
| 1 Year | 16.86 | 49.5799 | 15.76 | 30.34 | 903,952 | 27.15 | 161.03% |
| 3 Years | 16.62 | 49.5799 | 15.23 | 26.34 | 490,362 | 27.39 | 164.80% |
| 5 Years | 23.25 | 49.5799 | 10.63 | 25.06 | 338,453 | 20.76 | 89.29% |
Crinetics Pharmaceuticals Description
| Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. |
